Suppr超能文献

巨噬细胞对实体瘤的协同吞噬作用可引发持久的抗肿瘤反应。

Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses.

机构信息

Molecular and Cell Biophysics Lab, University of Pennsylvania, Philadelphia, PA, USA.

Physical Sciences-Oncology Center at Penn, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Nat Biomed Eng. 2023 Sep;7(9):1081-1096. doi: 10.1038/s41551-023-01031-3. Epub 2023 Apr 24.

Abstract

In solid tumours, the abundance of macrophages is typically associated with a poor prognosis. However, macrophage clusters in tumour-cell nests have been associated with survival in some tumour types. Here, by using tumour organoids comprising macrophages and cancer cells opsonized via a monoclonal antibody, we show that highly ordered clusters of macrophages cooperatively phagocytose cancer cells to suppress tumour growth. In mice with poorly immunogenic tumours, the systemic delivery of macrophages with signal-regulatory protein alpha (SIRPα) genetically knocked out or else with blockade of the CD47-SIRPα macrophage checkpoint was combined with the monoclonal antibody and subsequently triggered the production of endogenous tumour-opsonizing immunoglobulin G, substantially increased the survival of the animals and helped confer durable protection from tumour re-challenge and metastasis. Maximizing phagocytic potency by increasing macrophage numbers, by tumour-cell opsonization and by disrupting the phagocytic checkpoint CD47-SIRPα may lead to durable anti-tumour responses in solid cancers.

摘要

在实体瘤中,巨噬细胞的丰度通常与预后不良相关。然而,肿瘤细胞巢中的巨噬细胞簇与某些肿瘤类型的存活有关。在这里,我们通过使用肿瘤类器官,其中包含通过单克隆抗体调理的巨噬细胞和癌细胞,表明高度有序的巨噬细胞簇协同吞噬癌细胞以抑制肿瘤生长。在免疫原性差的肿瘤小鼠中,系统递送信号调节蛋白 α(SIRPα)基因敲除的巨噬细胞或阻断 CD47-SIRPα 巨噬细胞检查点的巨噬细胞与单克隆抗体联合使用,随后触发内源性肿瘤调理免疫球蛋白 G 的产生,大大提高了动物的存活率,并有助于提供持久的保护,防止肿瘤再挑战和转移。通过增加巨噬细胞数量、肿瘤细胞调理以及破坏吞噬检查点 CD47-SIRPα 来最大化吞噬效力,可能会导致实体癌产生持久的抗肿瘤反应。

相似文献

1
Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses.
Nat Biomed Eng. 2023 Sep;7(9):1081-1096. doi: 10.1038/s41551-023-01031-3. Epub 2023 Apr 24.
2
Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.
Cancer Immunol Immunother. 2022 Feb;71(2):473-489. doi: 10.1007/s00262-021-03010-6. Epub 2021 Jul 10.
3
Targeting HDAC6 improves anti-CD47 immunotherapy.
J Exp Clin Cancer Res. 2024 Feb 27;43(1):60. doi: 10.1186/s13046-024-02982-4.
4
SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
Nature. 2017 Apr 27;544(7651):493-497. doi: 10.1038/nature22076. Epub 2017 Apr 19.
6
Cancer immunotherapy targeting the CD47/SIRPα axis.
Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10.
7
Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.
Biomaterials. 2017 Mar;121:121-129. doi: 10.1016/j.biomaterials.2017.01.004. Epub 2017 Jan 3.
10
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis.
Front Immunol. 2020 Jan 28;11:18. doi: 10.3389/fimmu.2020.00018. eCollection 2020.

引用本文的文献

2
Clustered macrophages cooperate to eliminate tumors via coordinated intrudopodia.
Proc Natl Acad Sci U S A. 2025 Jul 8;122(27):e2425452122. doi: 10.1073/pnas.2425452122. Epub 2025 Jul 1.
3
Spatial omics technology potentially promotes the progress of tumor immunotherapy.
Br J Cancer. 2025 Jun 2. doi: 10.1038/s41416-025-03075-5.
4
Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy.
Sci Adv. 2025 May 23;11(21):eadw7191. doi: 10.1126/sciadv.adw7191. Epub 2025 May 21.
6
Syndecan-3 positively regulates the pro-inflammatory function of macrophages.
Cell Mol Life Sci. 2025 Apr 7;82(1):145. doi: 10.1007/s00018-025-05649-1.
7
Target cell adhesion limits macrophage phagocytosis and promotes trogocytosis.
bioRxiv. 2025 Feb 8:2025.02.06.636906. doi: 10.1101/2025.02.06.636906.
8
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Nat Med. 2025 Apr;31(4):1171-1182. doi: 10.1038/s41591-025-03495-z. Epub 2025 Feb 7.
9
β2 integrins impose a mechanical checkpoint on macrophage phagocytosis.
Nat Commun. 2024 Sep 18;15(1):8182. doi: 10.1038/s41467-024-52453-9.
10
In vitro co-culture models for studying organoids-macrophages interaction: the golden technology of cancer immunotherapy.
Am J Cancer Res. 2024 Jul 15;14(7):3222-3240. doi: 10.62347/BQFH7352. eCollection 2024.

本文引用的文献

1
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Nat Med. 2022 Feb;28(2):333-344. doi: 10.1038/s41591-021-01625-x. Epub 2022 Jan 13.
4
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis.
Nature. 2021 Sep;597(7877):549-554. doi: 10.1038/s41586-021-03879-4. Epub 2021 Sep 8.
5
Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation.
Cell Rep. 2021 Aug 24;36(8):109587. doi: 10.1016/j.celrep.2021.109587.
6
Primordial GATA6 macrophages function as extravascular platelets in sterile injury.
Science. 2021 Mar 5;371(6533). doi: 10.1126/science.abe0595.
7
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma.
Immunity. 2021 Mar 9;54(3):571-585.e6. doi: 10.1016/j.immuni.2021.01.001. Epub 2021 Jan 25.
8
Physical traits of cancer.
Science. 2020 Oct 30;370(6516). doi: 10.1126/science.aaz0868.
9
CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis.
Immunity. 2020 Aug 18;53(2):290-302.e6. doi: 10.1016/j.immuni.2020.07.008. Epub 2020 Aug 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验